Medplus unit faces drug license suspension orders in Karnataka
Optival Health Solutions Private Limited, a subsidiary of Medplus Health Services, received suspension orders for drug licenses at three stores in Karnataka due to violations of the Drugs and Cosmetics Act, 1940. The orders, issued by authorities in Bangalore and Belgaum, result in license suspensions ranging from one to two days. The company estimates a total potential revenue loss of ₹1.59 lakh from these regulatory actions.

*this image is generated using AI for illustrative purposes only.
Optival Health Solutions Private Limited, a subsidiary of medplus health services , has received suspension orders for drug licenses at three of its stores located in Karnataka. The orders were issued by the Assistant Director of the Drugs Control Administration in Bangalore Circle-3 and Belgaum Circle. The company disclosed that the suspensions were imposed due to violations under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The financial impact is estimated at a total potential revenue loss of ₹1.59 lakh.
The first order involves the suspension of the drug license for one day for a store situated at the Sarakki JP Nagar Metro Station. The second order also suspends the license for one day for a store located in Jaraganahalli. Both orders were received from the Bangalore Circle-3 authority. The third order, received from the Belgaum Circle authority, suspends the drug license for two days for a store situated at K C Road Chikkodi.
The following table details the specific actions taken and the estimated financial impact:
| Authority | Nature of Action | Date of Receipt | Violation | Potential Revenue Loss |
|---|---|---|---|---|
| Assistant Director, Drugs Control Administration, Bangalore Circle-3, Karnataka | Suspension of Drug License for one day (Sarakki JP Nagar Metro Station) | 14.07.2026 | Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 | Rs 0.77 lacs |
| Assistant Director, Drugs Control Administration, Bangalore Circle-3, Karnataka | Suspension of Drug License for one day (Jaraganahalli) | - | Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 | Rs 0.35 lacs |
| Assistant Director, Drugs Control Administration, Belgaum Circle, Karnataka | Suspension of Drug License for two days (K C Road Chikkodi) | - | Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 | Rs 0.47 lacs |
The disclosure was made in compliance with Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was submitted by Gangadi Madhukar Reddy, Managing Director and Chief Executive Officer of Medplus Health Services Limited. The information is available on the company's website and the exchanges.
Historical Stock Returns for Medplus Health Services
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.25% | -0.89% | -7.09% | -2.93% | -11.19% | -27.85% |
Will these regulatory violations trigger increased scrutiny from the Drugs Control Administration on other Medplus outlets?
Does the recurrence of Rule 65 violations indicate a need for systemic changes in the company's compliance training programs?
How might repeated regulatory actions affect investor confidence in Medplus Health Services' operational governance?































